Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1961 May 27;84(21):1177–1180.

Reserpine—A Comparison of Chronic Toxicity in Animals with Clinical Toxicity

J M Parker, C W Murphy
PMCID: PMC1939645  PMID: 13732848

Full text

PDF
1177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES J. M., DENZ F. A. Experimental methods used in determining chronic toxicity; a critical review. Pharmacol Rev. 1954 Jun;6(2):191–242. [PubMed] [Google Scholar]
  2. BORENSTEIN P., DABBAH M., BARE D. Contribution a l'etude de la reserpine en psychiatrie; résultats cliniques et électro-encephalographiques. Ann Med Psychol (Paris) 1956 Apr;114(4):545–580. [PubMed] [Google Scholar]
  3. BRODIE B. B., PLETSCHER A., SHORE P. A. Evidence that serotonin has a role in brain function. Science. 1955 Nov 18;122(3177):968–968. doi: 10.1126/science.122.3177.968. [DOI] [PubMed] [Google Scholar]
  4. CLARK M. L., SCHNEIDER E. M. The effect of intravenous reserpine on gastric acidity in man. Gastroenterology. 1955 Nov;29(5):877–881. [PubMed] [Google Scholar]
  5. DRENICK E. J. Reserpine in peptic ulcer. Am J Dig Dis. 1956 Dec;1(12):521–525. doi: 10.1007/BF02236125. [DOI] [PubMed] [Google Scholar]
  6. FREIS E. D. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med. 1954 Dec 16;251(25):1006–1008. doi: 10.1056/NEJM195412162512504. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES